STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
GKOS GLAUKOS CORPORATION StockScouter® Report
7
StockScouter® Score
GLAUKOS CORPORATION, a mid cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The multi-period measure of relative price change and consistency is well above average. Positive
- The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
Concerns
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- One or more analysts has modestly decreased quarterly earnings estimates for GKOS. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, growth stocks will be out of favor, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
C
C
F
A